Aflac (AFL) – Investment Analysts’ Recent Ratings Changes

Aflac (NYSE: AFL) has recently received a number of price target changes and ratings updates:

  • 11/18/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b)”.
  • 11/12/2026 – Aflac had its price target raised by Wells Fargo & Company from $116.00 to $124.00. They now have an “equal weight” rating on the stock.
  • 11/12/2026 – Aflac had its price target raised by Mizuho from $112.00 to $117.00. They now have an “underperform” rating on the stock.
  • 11/9/2026 – Aflac had its price target raised by Piper Sandler from $138.00 to $143.00. They now have an “overweight” rating on the stock.
  • 11/7/2026 – Aflac was upgraded by Wall Street Zen from “sell” to “hold”.
  • 11/3/2026 – Aflac was upgraded by Weiss Ratings from “buy (b+)” to “buy (a-)”.
  • 10/20/2026 – Aflac was downgraded by Weiss Ratings from “buy (a-)” to “buy (b+)”.
  • 10/15/2026 – Aflac had its price target raised by JPMorgan Chase & Co. from $116.00 to $119.00. They now have a “neutral” rating on the stock.
  • 10/12/2026 – Aflac had its price target lowered by Bank of America from $137.00 to $133.00. They now have a “buy” rating on the stock.
  • 10/12/2026 – Aflac had its price target lowered by Wells Fargo & Company from $122.00 to $116.00. They now have an “equal weight” rating on the stock.
  • 10/9/2026 – Aflac had its price target lowered by Keefe, Bruyette & Woods from $125.00 to $120.00. They now have a “market perform” rating on the stock.
  • 10/7/2026 – Aflac had its “underweight” rating reaffirmed by Barclays. They now have a $101.00 price target on the stock, up from $99.00.
  • 10/7/2026 – Aflac had its price target lowered by Mizuho from $116.00 to $107.00. They now have an “underperform” rating on the stock.
  • 10/6/2026 – Aflac had its “neutral” rating reaffirmed by UBS Group. They now have a $125.00 price target on the stock, up from $124.00.
  • 9/22/2026 – Aflac was upgraded by Weiss Ratings from “buy (b)” to “buy (a-)”.

Aflac Trading Down 0.5%

Shares of Aflac stock opened at $124.70 on Friday. Aflac Incorporated has a 52-week low of $105.76 and a 52-week high of $131.18. The stock’s 50-day simple moving average is $119.35 and its 200 day simple moving average is $116.98. The stock has a market capitalization of $61.68 billion, a P/E ratio of 18.18, a P/E/G ratio of 1.75 and a beta of 0.55. The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.11 and a current ratio of 0.11.

Aflac (NYSE:AFL – Get Free Report) last posted its earnings results on Wednesday, November 4th. The financial services provider reported $2.43 earnings per share for the quarter, topping the consensus estimate of $1.80 by $0.63. Aflac had a net margin of 21.24% and a return on equity of 12.82%. The firm had revenue of $4.30 billion during the quarter, compared to the consensus estimate of $4.12 billion. During the same quarter last year, the company earned $2.49 earnings per share. The company’s revenue was down 31.0% on a year-over-year basis. As a group, research analysts anticipate that Aflac Incorporated will post 7.37 EPS for the current year.

Aflac Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be given a dividend of $0.64 per share. This is an increase from Aflac’s previous quarterly dividend of $0.61. This represents a $2.56 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Wednesday, February 17th. Aflac’s dividend payout ratio (DPR) is currently 35.57%.

Insider Transactions at Aflac

In other Aflac news, major shareholder Post Holdings Co. Ltd. Japan sold 19,500 shares of the firm’s stock in a transaction on Tuesday, November 17th. The shares were sold at an average price of $127.95, for a total value of $2,495,025.00. Following the completion of the transaction, the insider directly owned 50,039,399 shares of the company’s stock, valued at $6,402,541,102.05. This trade represents a 0.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Joseph L. Moskowitz sold 600 shares of the stock in a transaction on Monday, November 9th. The stock was sold at an average price of $124.99, for a total value of $74,994.00. Following the completion of the sale, the director owned 32,119 shares in the company, valued at $4,014,553.81. This trade represents a 1.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 701,692 shares of company stock worth $82,550,167 in the last three months. 0.80% of the stock is currently owned by insiders.

Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.

Read More

Receive News & Ratings for Aflac Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.